ProMedica is pleased to announce the enrollment of the first patient in a national trial that studies a new treatment for people suffering a subdural hematoma, a neurological condition.
A subdural hematoma occurs when blood collects in the tissue surrounding the brain. It is most commonly caused by trauma, such as car accidents or falls but may occur in the setting of blood thinners or spontaneously. This condition can be very serious and may even result in death or disability.
“The trial involves a glue-like substance that is injected into the leaking blood vessel in an attempt to shut down the blood vessel and prevent a recurrent bleed,” said Syed Zaidi, MD, ProMedica Physicians Neurology, “This could be a huge advancement in the treatment of subdural hematomas.”
Participating in the study does not change the length of stay in the hospital for the patients. Patients follow a regular standard of care other than enrolling to treatment or observation in the study.
“The fact that our stroke team at ProMedica is not only participating in national clinical trials, but leading the way by enrolling the first patient, demonstrates our deep commitment to exceptional clinical care,” said Dawn Buskey, ProMedica president of acute care.
Recent Press Releases
ProMedica Achieves Credit Rating Upgrade from Moody’s
Elevating the organization's credit rating to investment grade
Henry County Hospital and ProMedica Announce Planned Affiliation to Support Local Healthcare for Future Generations
NAPOLEON, Ohio – October 6, 2026 – Henry County Hospital and ProMedica today announced their plan to enter into a new management affiliation designed to strengthen and sustain healthcare services for Henry County residents while preserving
The Blade: Lupus activist raises awareness in Toledo
Amala Ambati, MD, a rheumatologist at ProMedica, discusses the challenges of diagnosing lupus and emphasizes the importance of specialized caren
Aging Untold Extra: Parkinson’s Disease, preventing blood clots & more
Ahmad Younes, MD, interventional cardiologist and vascular specialist at ProMedica Jobst Vascular Institute, breaks down the facts and myths surrounding blood clots.
ProMedica Flower Hospital’s Obstetrics Program Transitioning to ProMedica Toledo Hospital, Creating an Enhanced OB Program
Flower Hospital Looking to Enhance or Expand Other Services on its Campus
ProMedica Monroe Cancer Center Unveils New Cutting-Edge Linear Accelerator to Enhance Cancer Care
This multi-million-dollar investment is part of ProMedica’s ongoing commitment to expanding and modernizing health care services in the region.
Forbes Names ProMedica Among The Best Employers for New Graduates
ProMedica recognized on list of “The Best Employers for New Grads.”
ProMedica Leads Midwest with Adoption of Cutting-Edge Surgical Robotics Across System
ProMedica is first in the Midwest and third in the world to adopt this state-of-the-art technology system-wide.